However, experimental evidence demonstrates that cancer cells also express E-selectin ligands, supporting the idea that these cancer cells may use a similar mechanism to leukocytes for extravasating at inflammation sites, allowing CTCs to enter into foreign tissue during the metastatic process [28, 29]. This evidence concerns the gene SELE and cancer.